OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of pyrazole and spiropyrazoline analogs as multifunctional agents for treatment of Alzheimer’s disease
Gopichand Gutti, Devendra Kumar, Pankaj Paliwal, et al.
Bioorganic Chemistry (2019) Vol. 90, pp. 103080-103080
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 85

Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
Aida Iraji, Mahsima Khoshneviszadeh, Omidreza Firuzi, et al.
Bioorganic Chemistry (2020) Vol. 97, pp. 103649-103649
Closed Access | Times Cited: 85

Development of multifunctional fluorescence-emitting potential theranostic agents for Alzheimer’s disease
Nilesh Gajanan Bajad, Gajendra T.A., Mansi Kothari, et al.
Talanta (2025) Vol. 287, pp. 127574-127574
Closed Access | Times Cited: 1

Discovery of pyrazoline analogs as multi-targeting cholinesterase, β-secretase and Aβ aggregation inhibitors through lead optimization strategy
Nilesh Gajanan Bajad, Jatin Jangra, T A Gajendra, et al.
International Journal of Biological Macromolecules (2025), pp. 140436-140436
Closed Access | Times Cited: 1

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1

Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer’s Disease Therapy
Digambar Kumar Waiker, Akash Verma, Akhilesh Akhilesh, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2217-2242
Closed Access | Times Cited: 20

Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease
Gopichand Gutti, Jennifer Leifeld, Kakarla Ramakrishna, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115670-115670
Closed Access | Times Cited: 18

Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease
Nilesh Gajanan Bajad, Ravi Bhushan Singh, Gajendra T.A., et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107082-107082
Closed Access | Times Cited: 6

Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors
Ankit Ganeshpurkar, Ravi Singh, Pravin Gore, et al.
Molecular Simulation (2019) Vol. 46, Iss. 3, pp. 169-185
Open Access | Times Cited: 37

Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access

Development of Donor–Acceptor Architecture-Based Potential Theranostic Fluorescent Probes for Alzheimer’s Disease
Nilesh Gajanan Bajad, Gajendra T.A., Khushboo Sharma, et al.
ACS Chemical Neuroscience (2025)
Closed Access

Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease
Gopichand Gutti, Kakarla Ramakrishna, Devendra Kumar, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111613-111613
Closed Access | Times Cited: 34

A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease
Ashish Patel, Drashti Shah, Yug Patel, et al.
Current Drug Targets (2022) Vol. 24, Iss. 3, pp. 225-246
Closed Access | Times Cited: 16

Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer’s: Design, Synthesis, and Biological Evaluation
Shraddha Manish Gupta, Ashok Behera, Neetesh Kumar Jain, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 94-94
Open Access | Times Cited: 16

Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox
Moulay Ahfid El Alaouy, Marwa Alaqarbeh, Mohamed Ouabane, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9547-9560
Closed Access | Times Cited: 10

Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach
Ankit Ganeshpurkar, Ravi Singh, Devendra Kumar, et al.
International Journal of Biological Macromolecules (2022) Vol. 203, pp. 195-211
Closed Access | Times Cited: 14

Highly efficient, catalyst-free, one-pot sequential four-component synthesis of novel spiroindolinone-pyrazole scaffolds as anti-Alzheimer agents: in silico study and biological screening
Hormoz Pourtaher, Yasaman Mohammadi, Alireza Hasaninejad, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 207-222
Closed Access | Times Cited: 7

Design, synthesis and biological evaluation of novel copper-chelating acetylcholinesterase inhibitors with pyridine and N-benzylpiperidine fragments
Yeheng Zhou, Wei Sun, Jiale Peng, et al.
Bioorganic Chemistry (2019) Vol. 93, pp. 103322-103322
Closed Access | Times Cited: 21

Synthesis of 4-Aminopyrazol-5-ols as Edaravone Analogs and Their Antioxidant Activity
Yanina V. Burgart, Галина Ф. Махаева, О. П. Красных, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7722-7722
Open Access | Times Cited: 10

Synthesis and characterization of a series of acylpyrazolone transition metal complexes: Crystal structures and catalytic performance in the epoxidation of cyclooctene
Maryam Esfahani, Mahdi Behzad, Michal Dušek, et al.
Inorganica Chimica Acta (2020) Vol. 508, pp. 119637-119637
Closed Access | Times Cited: 13

Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones
Shivani Jaiswal, Akhilesh Akhilesh, Ankit Uniyal, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 60, pp. 116698-116698
Closed Access | Times Cited: 7

Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson's disease: An approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies
Pratigya Tripathi, Ankit Ganeshpurkar, Sushil Kumar Singh, et al.
International Journal of Biological Macromolecules (2022) Vol. 228, pp. 453-466
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top